Document:

<PAGE>

                                                                    EXHIBIT 10.2

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR ANY STATE SECURITIES LAW AND IT MAY NOT BE SOLD OR OTHERWISE TRANSFERRED BY
ANY PERSON, INCLUDING A PLEDGEE, UNLESS EITHER A REGISTRATION STATEMENT WITH
RESPECT TO IT SHALL BE EFFECTIVE UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR THE CORPORATION SHALL HAVE RECEIVED AN OPINION OF COUNSEL SATISFACTORY TO THE
CORPORATION THAT THE TRANSACTION IS EXEMPT FROM REGISTRATION UNDER SUCH ACT AND
ANY APPLICABLE STATE SECURITIES LAWS.

                           INTERLEUKIN GENETICS, INC.

                              TERM PROMISSORY NOTE

$_______________                                                  August 9, 2002
                                                          Waltham, Massachusetts

     FOR VALUE RECEIVED, Interleukin Genetics, Inc., a Delaware corporation (the
"Borrower") hereby promises to pay to the order of [______________] (the
"Lender"), in lawful money of the United States of America at such place or
places or to such other party or parties as the Lender may from time to time
designate, the principal sum of [______________] THOUSAND DOLLARS ($___,000.00).

     The Borrower shall pay the entire outstanding principal balance of this
Note on August 9, 2003 (the "Maturity Date"). Interest shall accrue on the
outstanding principal balance of this Note at a fixed interest rate per annum
equal to FIFTEEN PERCENT (15%) . In addition to the payment of principal
hereunder, all accrued interest then outstanding shall be payable in arrears on
the Maturity Date. If any amount due under this Note is not paid on the due
date, whether as stated or by acceleration, interest on the unpaid principal
balance shall continue to accrue. The Borrower may voluntarily prepay this Note
in whole or in part at any time and from time to time without penalty, together
with interest accrued on the amount prepaid through the date of prepayment.

     Upon the occurrence of any one or more of the following events (each, an
"Event of Default"), the Lender at its option may declare all amounts due
hereunder, including, without limitation, the entire unpaid principal balance of
this Note and any accrued, unpaid interest thereon, to be immediately due and
payable:

     (a) The failure to make any payment of principal or interest due pursuant
     to the terms of this Note on or before the due date;

<PAGE>

     (b) (i) The commencement by the Borrower of a voluntary case under 11
     U.S.C. Section 101 ET. SEQ. (the "Bankruptcy Code") or any foreign, federal
     or state bankruptcy, insolvency or other similar law now or hereafter in
     effect, or (ii) the consent by the Borrower to the entry of an order for
     relief in an involuntary bankruptcy or similar case, or to the conversion
     of an involuntary case to a voluntary case, under any such law, or (iii)
     the consent by the Borrower to the appointment of, or the taking of
     possession by, a receiver, trustee or other custodian for all or a
     substantial part of its properties, or (iv) the making by the Borrower of
     any assignment for the benefit of creditors, or (v) the discontinuance of
     business, dissolution, winding up, liquidation or cessation of existence by
     the Borrower; or

     (c) (i) The entry by a court of a decree or order for relief with respect
     to the Borrower in an involuntary case under the Bankruptcy Code or any
     applicable foreign, federal or state bankruptcy, insolvency or other
     similar law now or hereafter in effect, which decree or order is not stayed
     or dismissed within 60 days of the entry thereof, or (ii) the entry by a
     court of a decree or order for the appointment of a receiver, liquidator,
     sequestrator, trustee, custodian or other person having similar powers over
     the Borrower or over all or a substantial part of its properties;

     Upon the occurrence and continuance of any Event of Default hereunder, (i)
the Lender may declare the principal balance of this Note to be immediately due
and payable, PROVIDED, HOWEVER, in the case of an Event of Default described in
paragraphs (b) or (c) above, all amounts payable by the Borrower hereunder,
including, without limitation, the principal balance and all accrued interest on
this Note, shall automatically become immediately due and payable, without
notice, action or election by the Lender, and (ii) the Lender may enforce any
other rights granted pursuant to this Note, any other document, or by applicable
law.

     In the event that any court of competent jurisdiction shall determine that
any provision, or portion thereof, contained in this Note shall be unenforceable
in any respect, then such provision shall be deemed limited to the extent that
such court deems it enforceable, and the remaining provisions of this Note shall
nevertheless remain in full force and effect.

     None of the terms or provisions of this Note may be excluded, modified, or
amended except by a written instrument duly executed on behalf of both the
Borrower and the Lender expressly referring hereto and setting forth the
provision so excluded, modified or amended. No waiver or forbearance of any of
the rights and remedies of the Lender hereunder shall be effective unless made
specifically in a writing signed by the Lender, and any such waiver or
forbearance shall be effective only in the specific instance and for the
specific purpose for which given.

     This Note shall be binding upon the Borrower and shall be enforceable
against the Borrower and its heirs, successors and representatives, and shall
inure to the benefit of the Lender and its successors, endorsees and assigns.
The Borrower may not assign this Note or any rights hereunder without the
express written consent of the Lender.

                                      -2-

<PAGE>

     THIS NOTE IS DELIVERED TO THE LENDER BY THE BORROWER AT ITS PRINCIPAL
OFFICE IN WALTHAM, MASSACHUSETTS AND SHALL BE GOVERNED BY AND ENFORCED IN
ACCORDANCE WITH THE LAWS OF THE COMMONWEALTH OF MASSACHUSETTS WITHOUT REGARD TO
ITS PRINCIPLES OF CONFLICTS OF LAWS. THE BORROWER AND LENDER EACH SUBMIT TO THE
JURISDICTION OF THE COURTS OF THE COMMONWEALTH OF MASSACHUSETTS AND OF THE
UNITED STATES DISTRICT COURTS SITUATED THEREIN FOR ALL PURPOSES WITH RESPECT TO
THIS NOTE.

     IN WITNESS WHEREOF, the Borrower has caused this Note to be executed as an
instrument under seal by its duly authorized officer as of the date first above
written.

                                   INTERLEUKIN GENETICS, INC.

                                   By:
                                      ------------------------------------------
                                   Name:
                                   Title:

                                      -3-<PAGE>

                                                                    EXHIBIT 10.3

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAW AND THEY MAY
NOT BE SOLD OR OTHERWISE TRANSFERRED BY ANY PERSON, INCLUDING A PLEDGEE, UNLESS
EITHER A REGISTRATION STATEMENT WITH RESPECT TO SUCH SHARES SHALL BE EFFECTIVE
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE CORPORATION SHALL HAVE
RECEIVED AN OPINION OF COUNSEL SATISFACTORY TO THE CORPORATION THAT THE
TRANSACTION IS EXEMPT FROM REGISTRATION UNDER SUCH ACT AND ANY APPLICABLE STATE
SECURITIES LAWS.

    VOID AFTER 5:00 P.M. EASTERN TIME ON AUGUST 9, 2012 ("EXPIRATION DATE").

No.

                           INTERLEUKIN GENETICS, INC.

                      WARRANT TO PURCHASE       SHARES OF
            COMMON STOCK, $0.001 PAR VALUE PER SHARE ("COMMON STOCK")

     For VALUE RECEIVED, (the "Warrantholder"), is entitled to purchase, subject
to the provisions of this Warrant, from Interleukin Genetics, Inc., a Delaware
corporation ("Company"), at any time not later than 5:00 P.M., Eastern time, on
the Expiration Date, at an exercise price per share equal to $2.50 (the exercise
price in effect being herein called the "Warrant Price"), shares (the "Warrant
Shares") of Common Stock. The number of Warrant Shares purchasable upon exercise
of this Warrant and the Warrant Price shall be subject to adjustment from time
to time as described herein.

     Section 1.  REGISTRATION. The Company shall maintain books for the transfer
and registration of the Warrant. Upon the initial issuance of the Warrant, the
Company shall issue and register the Warrant in the name of the Warrantholder.

     Section 2.  TRANSFERS. As provided herein, this Warrant may be transferred
only pursuant to a registration statement filed under the Securities Act of
1933, as amended (the "Securities Act") or an exemption from such registration.
Subject to such restrictions, the Company shall transfer this Warrant from time
to time upon the books to be maintained by the Company for that purpose, upon
surrender thereof for transfer properly endorsed or accompanied by appropriate
instructions for transfer and such other documents as may be reasonably required
by the Company to establish that such transfer is being made in accordance with
the terms hereof, and a new Warrant shall be issued to the transferee and the
surrendered Warrant shall be canceled by the Company.

<PAGE>

     Section 3. EXERCISE OF WARRANT. Subject to the provisions hereof, the
Warrantholder may exercise this Warrant in whole or in part at any time upon
surrender of the Warrant, together with delivery of the duly executed Warrant
exercise form attached hereto (the "Exercise Agreement") and payment by cash,
certified check or wire transfer of funds in an amount equal to the aggregate
Warrant Price for that number of Warrant Shares then being purchased, to the
Company during normal business hours on any business day at the Company's
principal executive offices (or such other office or agency of the Company as it
may designate by notice to the holder hereof). The Warrant Shares so purchased
shall be deemed to be issued to the Warrantholder, as the record owner of such
shares, as of the close of business on the date on which this Warrant shall have
been surrendered (or evidence of loss, theft or destruction thereof and security
or indemnity satisfactory to the Company shall have been provided to the
Company), the Warrant Price shall have been paid and the completed Exercise
Agreement shall have been delivered. Certificates for the Warrant Shares so
purchased, representing the aggregate number of shares specified in the Exercise
Agreement, shall be delivered to the Warrantholder hereof within a reasonable
time, not exceeding ten (10) business days, after this Warrant shall have been
so exercised. The certificates so delivered shall be in such denominations as
may be requested by the Warranthholder hereof and shall be registered in the
name of the Warrantholder. If this Warrant shall have been exercised only in
part, then, unless this Warrant has expired, the Company shall, at its expense,
at the time of delivery of such certificates, deliver to the Warrantholder a new
Warrant representing the number of shares with respect to which this Warrant
shall not then have been exercised.

          Each exercise hereof shall constitute the representation and warranty
of the Warrantholder to the Company that the representations and warranties
contained in Note and Warrant Subscription Agreement, dated as of July , 2002,
by and among the Company and the Warrantholder (the "subscription Agreement")
are true and correct in all material respects with respect to the Warrantholder
as of the time of such exercise.

     Section 4.  COMPLIANCE WITH THE SECURITIES ACT OF 1933.

          (a) UNREGISTERED SECURITIES. The Warrantholder acknowledges that this
Warrant and the Warrant Shares have not been registered under the Securities
Act, and agrees not to sell, pledge, distribute, offer for sale, transfer or
otherwise dispose of this Warrant or any Warrant Shares in the absence of (i) an
effective registration statement under the Securities Act covering this Warrant
or such Warrant Shares and registration or qualification of this Warrant or such
Warrant Shares under any applicable "blue sky" or state securities law then in
effect, or (ii) an opinion of counsel, satisfactory to the Company, that such
registration and qualification are not required. The Company may delay issuance
of the Warrant Shares until completion of any action or obtaining of any
consent, which the Company deems necessary under any applicable law (including
without limitation state securities or "blue sky" laws).

          (b) INVESTMENT LETTER. Without limiting the generality of Section
4(a), unless the offer and sale of any shares of Warrant Shares shall have been
effectively registered under the Securities Act, the Company shall be under no
obligation to issue the Warrant Shares unless and until the Warrantholder shall
have executed an investment letter in form and substance

                                       2

<PAGE>

satisfactory to the Company, including a warranty at the time of such exercise
that the Warrantholder is acquiring such shares for its own account, for
investment and not with a view to, or for sale in connection with, the
distribution of any such shares.

     Section 5.  MUTILATED OR MISSING WARRANTS. In case this Warrant shall be
mutilated, lost, stolen, or destroyed, the Company shall issue in exchange and
substitution of and upon cancellation of the mutilated Warrant, or in lieu of
and substitution for the Warrant lost, stolen or destroyed, a new Warrant of
like tenor and for the purchase of a like number of Warrant Shares, but only
upon receipt of evidence reasonably satisfactory to the Company of such loss,
theft or destruction of the Warrant, and with respect to a lost, stolen or
destroyed Warrant, reasonable indemnity or bond with respect thereto, if
requested by the Company.

     Section 6.  RESERVATION OF COMMON STOCK. The Company hereby represents and
warrants that there have been reserved, and the Company shall at all applicable
times keep reserved until issued (if necessary) as contemplated by this Section
6, out of the authorized and unissued Common Stock, sufficient shares to provide
for the exercise of the rights of purchase represented by the Warrant. The
Company agrees that all Warrant Shares issued upon exercise of the Warrant shall
be, at the time of delivery of the certificates for such Warrant Shares, duly
authorized, validly issued, fully paid and non-assessable shares of Common Stock
of the Company.

     Section 7.  ADJUSTMENTS. Subject and pursuant to the provisions of this
Section 7, the Warrant Price and number of Warrant Shares subject to this
Warrant shall be subject to adjustment from time to time as set forth
hereinafter.

          (a) CHANGES IN COMMON STOCK. If the Company shall (i) combine the
outstanding shares of Common Stock into a lesser number of shares, (ii)
subdivide the outstanding shares of Common Stock into a greater number of
shares, or (iii) issue additional shares of Common Stock as a dividend or other
distribution with respect to the Common Stock, the number of Warrant Shares
shall be equal to the number of shares which the Warrantholder would have been
entitled to receive after the happening of any of the events described above if,
immediately prior to the happening of such event, such Warrantholder had held
the number of shares of Common Stock which were then purchasable upon the
exercise of this Warrant, such adjustment to become effective concurrently with
the effectiveness of such event. The Warrant Price in effect immediately prior
to any such combination of Common Stock shall, upon the effectiveness of such
combination, be proportionately increased. The Warrant Price in effect
immediately prior to any such subdivision of Common Stock or at the record date
of such dividend shall upon the effectiveness of such subdivision or immediately
after the record date of such dividend be proportionately reduced.

          (b) REORGANIZATIONS AND RECLASSIFICATIONS. If there shall occur any
capital reorganization or reclassification of the Common Stock (other than a
change in par value or a subdivision or combination as provided for in Section
7(a)), then, as part of any such reorganization or reclassification, lawful
provision shall be made so that the Warrantholder shall have the right
thereafter to receive upon the exercise hereof the kind and amount of shares of

                                       3

<PAGE>

stock or other securities or property which such Warrantholder would have been
entitled to receive if, immediately prior to any such reorganization or
reclassification, such Warrantholder had held the number of shares of Common
Stock which were then purchasable upon the exercise of this Warrant. In any such
case, appropriate adjustment (as reasonably determined by the Board of Directors
of the Company) shall be made in the application of the provisions set forth
herein with respect to the rights and interests thereafter of the Warrantholder
such that the provisions set forth in this Section 7 (including provisions with
respect to adjustment of the Warrant Price) shall thereafter be applicable, as
nearly as is reasonably practicable, in relation to any shares of stock or other
securities or property thereafter deliverable upon the exercise of this Warrant.

          (c) MERGER, CONSOLIDATION OR SALE OF ASSETS. Subject to the provisions
of Section 10, if there shall be a merger or consolidation of the Company with
or into another corporation (other than a merger or reorganization involving
only a change in the state of incorporation of the Company or the acquisition by
the Company of other businesses where the Company survives as a going concern),
or the sale of all or substantially all of the Company's capital stock or assets
to any other person, then as a part of such transaction, provision shall be made
so that the Warrantholder shall thereafter be entitled to receive the number of
shares of stock or other securities or property of the Company, or of the
successor corporation resulting from the merger, consolidation or sale, to which
the Warrantholder would have been entitled if the Warrantholder had exercised
its rights pursuant to the Warrant immediately prior thereto. In any such case,
appropriate adjustment shall be made in the application of the provisions of
this Section 7 to the end that the provisions of this Section 7 shall be
applicable after that event in as nearly equivalent a manner as may be
practicable.

          (d) CERTIFICATE OF ADJUSTMENT. When any adjustment is required to be
made in the Warrant Price, the Company shall promptly mail to the Warrantholder
a certificate setting forth the Warrant Price after such adjustment and setting
forth a brief statement of the facts requiring such adjustment. Delivery of such
certificate shall be deemed to be a final and binding determination with respect
to such adjustment unless challenged by the Warrantholder within ten (10) days
of receipt thereof. Such certificate shall also set forth the kind and amount of
stock or other securities or property into which this Warrant shall be
exercisable following the occurrence of any of the events specified in this
Section 7.

         Section 8. FRACTIONAL INTEREST. The Company shall not be required to
issue fractions of Warrant Shares upon the exercise of the Warrant. If any
fraction of a Warrant Share would, except for the provisions of this Section, be
issuable upon the exercise of the Warrant (or specified portions thereof), the
fractional share shall be disregarded and the number of shares to be issued upon
exercise shall be the number of whole shares only.

     Section 9.  BENEFITS. Nothing in this Warrant shall be construed to give
any person, firm or corporation (other than the Company and the Warrantholder)
any legal or equitable right, remedy or claim, it being agreed that this Warrant
shall be for the sole and exclusive benefit of the Company and the
Warrantholder.

                                       4

<PAGE>

     Section 10.  TERMINATION UPON CERTAIN EVENTS. If there shall be a merger or
consolidation of the Company with or into another corporation (other than a
merger or reorganization involving only a change in the state of incorporation
of the Company or the acquisition by the Company of other businesses where the
Company survives as a going concern), or the sale of all or substantially all of
the Company's capital stock or assets to any other person, or the liquidation or
dissolution of the Company, then as a part of such transaction, at the Company's
option, either:

          (a) provision shall be made so that the Warrantholder shall thereafter
be entitled to receive the number of shares of stock or other securities or
property of the Company, or of the successor corporation resulting from the
merger, consolidation or sale, to which the Warrantholder would have been
entitled if the Warrantholder had exercised its rights pursuant to the Warrant
immediately prior thereto (and, in such case, appropriate adjustment shall be
made in the application of the provisions of this Section 10(a) to the end that
the provisions of Section 7 shall be applicable after that event in as nearly
equivalent a manner as may be practicable); or

          (b) this Warrant shall terminate on the effective date of such merger,
consolidation or sale (the "Termination Date") and become null and void,
provided that if this Warrant shall not have otherwise terminated or expired,
(1) the Company shall have given the Warrantholder written notice of such
Termination Date at least ten (10) business days prior to the occurrence thereof
and (2) the Warrantholder shall have the right until 5:00 p.m., Eastern Standard
Time, on the day immediately prior to the Termination Date to exercise its
rights hereunder to the extent not previously exercised.

     Section 11.  Certificates delivered to the Warrantholder pursuant to
Section 3 hereof shall bear the following legends or legends in a substantially
similar form:

     THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
     UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAW
     AND THEY MAY NOT BE SOLD OR OTHERWISE TRANSFERRED BY ANY PERSON, INCLUDING
     A PLEDGEE, UNLESS EITHER A REGISTRATION STATEMENT WITH RESPECT TO SUCH
     SHARES SHALL BE EFFECTIVE UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
     THE CORPORATION SHALL HAVE RECEIVED AN OPINION OF COUNSEL SATISFACTORY TO
     THE CORPORATION THAT THE TRANSACTION IS EXEMPT FROM REGISTRATION UNDER SUCH
     ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

     THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A REGISTRATION
     RIGHTS AGREEMENT DATED AUGUST 9, 2002, A COPY OF WHICH IS AVAILABLE FOR
     INSPECTION AT THE OFFICES OF THE COMPANY OR WILL BE MADE AVAILABLE UPON
     REQUEST.

                                       5

<PAGE>

     Section 12.  NO RIGHTS AS STOCKHOLDER. Until the exercise of this Warrant,
the Warrantholder shall not have or exercise any rights by virtue hereof as a
stockholder of the Company.

     Section 13.  NOTICES. Any notice pursuant hereto to be given or made by the
Warrantholder to or on the Company shall be sufficiently given or made if sent
by certified mail, return receipt requested, postage prepaid, addressed as
follows:

          Interleukin Genetics, Inc.
          135 Beaver Street, 2nd Floor
          Waltham, MA 02452
          Attn:  Fenel Eloi
          Fax:  781/398-0720

     with a copy to:

          Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
          One Financial Center
          Boston, MA 02111
          Attn:  Stanford N. Goldman, Jr.
          Fax:  617-542-2241

or such other address as the Company may specify in writing by notice to the
Warrantholder complying as to delivery with the terms of this Section 13.

     Any notice pursuant hereto to be given or made by the Company to or on the
Warrantholder shall be sufficiently given or made if personally delivered or if
sent by an internationally recognized courier services by overnight or two-day
service, to the address set forth on the books of the Company or, as to each of
the Company and the Warrantholder, at such other address as shall be designated
by such party by written notice to the other party complying as to delivery with
the terms of this Section 13. All such notices, requests, demands, directions
and other communications shall, when sent by courier be effective two (2) days
after delivery to such courier as provided and addressed as aforesaid.

     Section 14.  REGISTRATION RIGHTS. The initial holder of this Warrant is
entitled to the benefit of certain registration rights in respect of the Warrant
Shares as provided in the Registration Rights Agreement dated as of as of August
9, 2002.

     Section 15.  SUCCESSORS. All the covenants and provisions hereof by or for
the benefit of the Warrantholder shall bind and inure to the benefit of its
respective successors and assigns hereunder.

     Section 16.  GOVERNING LAW. This Warrant shall be deemed to be a contract
made under the laws of The Commonwealth of Massachusetts, without giving effect
to its conflict of

                                       6

<PAGE>

law principles, and for all purposes shall be construed in accordance with the
laws of said Commonwealth.

     Section 17.  WAIVERS AND MODIFICATIONS. Any term or provision of this
Warrant may be waived only by written document executed by the party entitled to
the benefits of such terms or provisions. The terms and provisions of this
Warrant may be modified or amended only by written agreement executed by the
Company and the Warrantholder.

         [THE REMAINDER OF THIS PAGE HAS BEEN INTENTIONALLY LEFT BLANK]

                                       7

<PAGE>

     IN WITNESS WHEREOF, the Company has caused this Warrant to be duly
executed, as of this ____ day of August, 2002.

                                 INTERLEUKIN GENETICS, INC.

                                  By:
                                     -----------------------------------------
                                  Name:
                                  Title:

                                       8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00044-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00044-of-00352.parquet"}]]